005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 11,580.00
−0.43%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- KRW 236
- Revenue estimate
- KRW 41.8B
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- KRW 173
- EPS estimate
- KRW 213
- Revenue actual
- KRW 39.0B
- Revenue estimate
- KRW 42.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -9.4%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | KRW 213 | KRW 173 | Miss -18.80% | KRW 39.0B |
| May 12, 2026 | KRW 203 | KRW 203 | In line | KRW 36.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026